, Tracking Stock Market Picks
Enter Symbol:
Bristol-myers Squibb Company (BMY) [hlAlert]

up 173.22 %

Bristol-myers Squibb Company (BMY) rated Outperform by Wells Fargo

Posted on: Friday,  Oct 9, 2009  8:25 AM ET by Wells Fargo

Wells Fargo rated Outperform Bristol-myers Squibb Company (NYSE: BMY) on 10/09/2009, when the stock price was $22.26. Since
then, Bristol-myers Squibb Company has gained 173.23% as of 12/01/2015's recent price of $60.82.
If you would have followed this Wells Fargo's recommendation on BMY, you would have gained 173.22% of your investment in 2244 days.

Bristol-Myers Squibb Company is a global leader in the research and development of innovative lifesaving and life-enhancing treatments for heart disease; high blood pressure; stroke; diabetes; cancer; HIV/AIDS and other infectious diseases; depression, schizophrenia and other mental disorders; pain; and other conditions.

The investment research content is provided by Wells Capital Management, a registered investment adviser and wholly owned subsidiary of Wells Fargo Bank, N.A. Our economists’ expertise on domestic markets, and national and global trends, is an important resource to the firm. Wells Capital Management economists are known for their thoughts on investment strategy, macro-economic forecasts and other top-down analysis, and share their views on bonds, midcaps and liquidity management in their publications.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/9/2009 8:25 AM Buy
as of 12/31/2009
1 Week up  1.16 %
1 Month up  2.96 %
3 Months up  17.07 %
1 YTD up  17.07 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy